Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial (Q34562932)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial (English)

1 reference

Europe PubMed Central

3 August 2017

phase III clinical trial

0 references

multicenter clinical trial

0 references

David A. Bluemke

object named as

David A Bluemke

3

0 references

Douglas H Sheafor

object named as

Douglas H Sheafor

10

0 references

Richard Semelka

13

object named as

Richard C Semelka

1 reference

Europe PubMed Central

3 August 2017

author name string

Steven S Raman

1

1 reference

Europe PubMed Central

3 August 2017

Christopher Leary

2

1 reference

Europe PubMed Central

3 August 2017

Marco Amendola

4

1 reference

Europe PubMed Central

3 August 2017

Dushyant Sahani

5

1 reference

Europe PubMed Central

3 August 2017

Jeffrey D McTavish

6

1 reference

Europe PubMed Central

3 August 2017

Jeffrey Brody

7

1 reference

Europe PubMed Central

3 August 2017

Eric Outwater

8

1 reference

Europe PubMed Central

3 August 2017

Donald Mitchell

9

1 reference

Europe PubMed Central

3 August 2017

Jeff Fidler

11

1 reference

Europe PubMed Central

3 August 2017

Isaac R Francis

12

1 reference

Europe PubMed Central

3 August 2017

Kohkan Shamsi

14

1 reference

Europe PubMed Central

3 August 2017

Simone Gschwend

15

1 reference

Europe PubMed Central

3 August 2017

David R Feldman

16

1 reference

Europe PubMed Central

3 August 2017

Josy Breuer

17

1 reference

Europe PubMed Central

3 August 2017

United States EOB Study Group

18

1 reference

Europe PubMed Central

3 August 2017

publication date

1 March 2010

1 reference

Europe PubMed Central

3 August 2017

Journal of Computer Assisted Tomography

1 reference

Europe PubMed Central

3 August 2017

34

1 reference

Europe PubMed Central

3 August 2017

163-172

1 reference

Europe PubMed Central

3 August 2017

2

1 reference

Europe PubMed Central

3 August 2017

Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

7 July 2018

Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

7 July 2018

Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

7 July 2018

Contrast agents for MR imaging of the liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

7 July 2018

Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

7 July 2018

Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

7 July 2018

Hepatic metastases: basic principles and implications for radiologists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

7 July 2018

Surgical decision making for large bowel cancer metastatic to the liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

7 July 2018

A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

7 July 2018

Application of the McNemar test to non-independent matched pair data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

7 July 2018

Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

7 July 2018

Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

7 July 2018

Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

27 October 2018

Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

27 October 2018

Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3036163

27 October 2018

Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MnDPDP for MR imaging of the liver. Results from the European phase III studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative embolization of the common hepatic artery in preparation for radical pancreatectomy for pancreas body cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/20351497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/RCT.0B013E3181C89D87

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34562932&oldid=1555498251"